CK-MB to Total CK Ratio for Myocardial Injury
Total CK and CK-MB/CK ratios should not be used for diagnosing myocardial injury—cardiac troponin is the only recommended biomarker, with CK-MB mass (not ratios) as an acceptable alternative only when troponin is unavailable 1.
Primary Recommendation
The National Academy of Clinical Biochemistry guidelines explicitly state that total CK should not be used as a biomarker for MI diagnosis (Class III recommendation) 1. The CK-MB/total CK ratio is not mentioned in current guidelines as a diagnostic tool because:
- Cardiac troponin (I or T) is the preferred and only recommended biomarker for detecting myocardial injury, defined as values exceeding the 99th percentile of reference populations 1
- When troponin is unavailable, CK-MB mass (not activity, not ratios) measured by immunoassay is the acceptable alternative 1
- Total CK has poor cardiac specificity due to high skeletal muscle concentrations 1
Historical Context of CK-MB/CK Ratios
While CK-MB/total CK ratios were historically used, the evidence shows significant limitations:
Traditional Ratio Thresholds (Historical Only)
- Older research suggested a ratio of 2.5-3% (0.025-0.03) as the lower threshold, with values >5-6% suggesting cardiac origin 2
- One 1986 study proposed 80 ng/U as a cutoff for CK-MB mass/total CK activity to differentiate myocardial necrosis from skeletal muscle injury 2
- More recent data shows ratios around 10% (0.1) until peak CK is reached in STEMI patients, then dropping sharply 3
Critical Problems with Ratio-Based Diagnosis
The ratio approach fails in multiple clinical scenarios:
- Skeletal muscle injury produces CK-MB constituting 1-3% of total CK, causing false positives 1
- Trauma and burn patients show elevated ratios without myocardial involvement 2
- Post-CPR patients have elevated CK-MB with poor specificity for actual MI 4
- Muscular diseases cause massive CK-MB elevations (>200 μg/L) while troponin remains normal, proving CK-MB lacks cardiac specificity 5
Current Clinical Approach
When evaluating suspected myocardial injury:
- Measure cardiac troponin at presentation and 6-9 hours later 1
- Diagnostic threshold: Troponin >99th percentile with rise/fall pattern indicates myocardial necrosis 1
- If troponin unavailable: Use CK-MB mass with 99th percentile threshold (sex-specific), requiring 2 consecutive elevated samples showing rise/fall 1
- When CK-MB elevated but troponin normal (<99th percentile): Search for alternative non-cardiac etiologies 1
Key Pitfall to Avoid
Never rely on CK-MB/total CK ratios to "rule in" myocardial injury. Studies comparing these markers show that CK-MB ratios miss significant myocardial necrosis detected by troponin 6, and conversely produce false positives in skeletal muscle disease 5. The ratio adds no diagnostic value beyond absolute CK-MB mass measurement, which itself is inferior to troponin 1, 7.
Why Troponin Supersedes All CK-Based Testing
Troponin offers superior performance because:
- Cardiac-specific isoforms (cTnI, cTnT) unique to myocardium 1
- Fewer false positives with skeletal muscle injury, trauma, or surgery 1
- Superior risk stratification for adverse cardiac events even when CK-MB is normal 1, 8
- Detects smaller amounts of myocardial necrosis missed by CK-MB 1
In contemporary practice, calculating CK-MB/total CK ratios is obsolete and should be abandoned in favor of troponin-based diagnosis 1.